Harold Allen Santy, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Gaston Ave, Fairmont, WV 26554 Phone: 304-624-6554 Fax: 304-624-5223 |
Natalie Patton, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Kaufman Dr, Fairmont, WV 26554 Phone: 301-707-8112 |
Sharon R Clagett, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 941 Farms Dr, Fairmont, WV 26554 Phone: 304-367-0180 |
Amana Ahamad Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1539 Country Club Rd, Fairmont, WV 26554 Phone: 304-363-8479 |
Shannon Nease Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Kaufman Dr, Fairmont, WV 26554 Phone: 304-363-4891 |
Julia B Vanvolkenburg, MED/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Gaston Ave, Fairmont, WV 26554 Phone: 304-624-6554 Fax: 304-624-5223 |
News Archive
While lung cancer death rates among women in most of the United States have declined substantially in recent years, progress among women in a region covering central Appalachia and southern parts of the Midwest and in northern parts of the Midwest has lagged.
Slowly but steadily the U.S. health care community is moving into the digital age: shifting their medical records from paper to electronic information systems. This movement raises serious concerns about security and privacy of patients' medical information. In an attempt to put these concerns to rest, the U.S. Department of Health and Human Services has awarded $15 million to create a new center for health information and privacy.
Molecular Detection Inc. a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that its Detect-Ready MRSA assay has received its first independent validation in a study conducted at St. George's Healthcare NHS Trust, a leading teaching hospital in the UK.
Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its availability, detection relied on clinical exams and prostate specific antigen screening.
Noting "we are just three years away from the target date for achieving the U.N. Millennium Development Goals (MDGs) agreed by all ... U.N. member states back in 2000 to eradicate global poverty," Peter Piot, director of the London School of Hygiene and Tropical Medicine, in this Independent opinion piece reflects "on the critical role of health in and beyond the Millennium Development Goals" ahead of the second meeting of the U.N. Secretary General's High-Level Panel on the future strategy to fight global poverty, set to take place in London on Wednesday.
› Verified 5 days ago